ETFs positioned on Alkem Laboratories Limited

Name YTD change Weight AuM
+13.49%-.--% 27,154 M€
+23.94%-.--% 9,273 M€
-1.43%-.--% 21 M€
+8.55%-.--% 37 M€
+11.17%-.--% 67 M€
+23.33%0.43% 180 M€
-7.38%0.3% 99 M€
-9.04%0.22% 2 M€
-7.66%0.2% 6,661 M€
+30.27%0.2% 10 M€
+31.37%0.2% 38 M€
+31.38%0.2% 247 M€
-9.29%0.17% 5,254 M€
-7.20%0.16% 5 M€
-17.55%0.15% 108 M€
-7.10%0.13% 2,692 M€
-5.57%0.13% 2,189 M€
-9.50%0.12% 48 M€
+26.60%0.11% 42 M€
+26.73%0.11% 4,366 M€
+33.14%0.09% 148 M€
+51.47%0.07% 794 M€
-3.96%0.07% 44 M€
+66.28%0.06% 173 M€
-6.48%0.06% 77 M€
-.--%0.04% 7 M€
+15.21%0.04% 535 M€
+36.46%0.04% 168 M€
+28.03%0.04% 8,289 M€
+37.64%0.04% 1,049 M€
+39.13%0.04% 24,558 M€
+40.31%0.04% 103 M€
+21.86%0.04% 10 M€
+21.28%0.04% 859 M€
-.--%0.04% 11 M€
+25.97%0.03% 1,699 M€
+23.59%0.03% 268 M€
+27.08%0.03% 872 M€
+24.55%0.03% 2,106 M€
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
  1. Stock Market
  2. Stocks
  3. ALKEM Stock
  4. ETFs Alkem Laboratories Limited